INVO restructures NTI holdings with $4.8M note and preferred stock amendments

INVO Fertility, Inc.

• Exchanged 801,196 NTI shares (19.9% stake) for 6,300 NTI Series A Preferred shares, $1,000 stated value each.
• NTI issued INVO a $4.8M secured convertible promissory note at 7%, due Nov 2026, convertible upon Qualified IPO or sale.
• Exchanged Series C-1 Preferred held by GreenBlock and FNL for Series C-2 Preferred; amended certificates to add redemption rights and reduce conversion price to $1.61.
• Amended and Restated Debenture with FNL: $4.8M principal, maturity extended to Feb 2026, plus right to buy up to $10M additional Series C-2 Preferred.
• Decathlon and FNL released security interests in NTI assets to facilitate the transactions.